Adverum Biotechnologies, Inc. is a clinical-stage gene therapy company headquartered in Redwood City, California, dedicated to developing transformative therapeutic solutions for rare diseases and ophthalmic disorders. The company boasts a promising pipeline of gene therapy candidates that harness its proprietary adeno-associated virus (AAV) technologies, aiming to meet substantial unmet medical needs. By focusing on innovative treatments, Adverum is strategically positioned to enhance patient outcomes and solidify its presence within the rapidly advancing gene therapy landscape.
Click "Analyze" to generate stock analysis
ADVM Price Trend and Signals
ADVM Option Volumes & Open Interests (aggregated)
ADVM Put Call Ratios and IV (aggregated)
ADVM Financials
2025-10-24Neutralvolume_signal
Abnormal volume detected compared to 5-day moving average.
2025-10-24Neutralvolume_signal
Abnormal volume detected compared to 10-day moving average.
2025-10-24Neutralvolume_signal
Abnormal volume detected compared to 20-day moving average.
2025-10-24Neutralvolume_signal
Abnormal volume detected compared to 3 mon moving average.
2025-10-24Somewhat Bearishprice_signal
Monthly low detected.
2025-10-24Neutraloption_volume_signal
Abnormal option volume detected compared to 5-day moving average.
2025-10-24Neutraloption_volume_signal
Abnormal option volume detected compared to 10-day moving average.
2025-10-24Neutraloption_volume_signal
Abnormal option volume detected compared to 20-day moving average.
2025-10-24Neutraloption_volume_signal
Abnormal option volume detected compared to 3 mon moving average.